Showing results (721-730 of 3,172) with videos related to

Sort By:
Pageof 318
Translational Oncology|June 18, 2026
Combined inhibition of CDK4/6 and PI3K pathways exhibit highly synergistic activity and translational potential in Ewing sarcomaHelen F Gloege, Maria Ana Isabel C De Los Santos, Advaita Chakraborty, et al.
Translational Oncology|April 29, 2014
Real-Time Measurement of Functional Tumor Volume by MRI to Assess Treatment Response in Breast Cancer Neoadjuvant Clinical Trials: Validation of the Aegis SER Software PlatformDavid C Newitt, Sheye O Aliu, Neil Witcomb, et al.
Translational Oncology|June 19, 2026
Single-cell and spatial transcriptomics reveal lactate-active epithelial-immune cell crosstalk that reprograms the immune microenvironment in colorectal cancerHaisheng Lan, Yang Li, Hua Li, et al.
Translational Oncology|June 26, 2026
S100A10 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating JUND/TNC axis-mediated EMTZhixin Zheng, Anjie Peng, Ziyao Xi, et al.
Translational Oncology|June 27, 2026
Pan-cancer analysis identifies immunoproteasome as the predominant survival-associated component of antigen processing machineryJiun-I Lai, Chun-Yu Liu, Yi-Fang Tsai, et al.
Translational Oncology|August 3, 2026
Geriatric oncology at a crossroads: Advancing equity and access for elderly leukemia patients in underserved regionsEmmanuel Ifeanyi Obeagu
Translational Oncology|July 20, 2026
KLF16 promotes immune escape in hepatocellular carcinoma cells by upregulating PD-L1 expression via PRKDCShujia Kong, Chen Zhao, Fangyi Lu, et al.
Translational Oncology|July 16, 2026
The role of splicing factor SRSF3 in cancer progression: Mechanisms, biomarkers, and therapeutic implicationsShidong Wang, Hong Teng, Hongyan Han, et al.
Translational Oncology|July 29, 2026
Histology-derived prediction of a stromal remodeling program in pancreatic ductal adenocarcinoma with transcriptomic and spatial validationWenhao Bao, Tianying Wang, Xiaodan Xia, et al.
Translational Oncology|July 27, 2026
IGHG1⁺ plasma cells define an NF-κB-driven inflammatory program that shapes T-cell immunity and immunotherapy response in colorectal cancerRui-Feng Zhang, Wan-Ze Zhang, He Li, et al.
Pageof 318